The sphingolipid salvage pathway in ceramide metabolism and signaling
- PMID: 18191382
- PMCID: PMC2422835
- DOI: 10.1016/j.cellsig.2007.12.006
The sphingolipid salvage pathway in ceramide metabolism and signaling
Abstract
Sphingolipids are important components of eukaryotic cells, many of which function as bioactive signaling molecules. Of these, ceramide is a central metabolite and plays key roles in a variety of cellular responses, including regulation of cell growth, viability, differentiation, and senescence. Ceramide is composed of the long-chain sphingoid base, sphingosine, in N-linkage to a variety of acyl groups. Sphingosine serves as the product of sphingolipid catabolism, and it is mostly salvaged through reacylation, resulting in the generation of ceramide or its derivatives. This recycling of sphingosine is termed the "salvage pathway", and recent evidence points to important roles for this pathway in ceramide metabolism and function. A number of enzymes are involved in the salvage pathway, and these include sphingomyelinases, cerebrosidases, ceramidases, and ceramide synthases. Recent studies suggest that the salvage pathway is not only subject to regulation, but it also modulates the formation of ceramide and subsequent ceramide-dependent cellular signals. This review focuses on the salvage pathway in ceramide metabolism, its regulation, its experimental analysis, and emerging biological functions.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2422835/bin/nihms-50556-f0001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2422835/bin/nihms-50556-f0002.gif)
Similar articles
-
The effect of altered sphingolipid acyl chain length on various disease models.Biol Chem. 2015 Jun;396(6-7):693-705. doi: 10.1515/hsz-2014-0310. Biol Chem. 2015. PMID: 25720066 Review.
-
Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.Prog Lipid Res. 2007 Mar;46(2):126-44. doi: 10.1016/j.plipres.2007.03.001. Epub 2007 Mar 14. Prog Lipid Res. 2007. PMID: 17449104 Review.
-
Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.Biol Chem. 2015 Jun;396(6-7):669-79. doi: 10.1515/hsz-2014-0302. Biol Chem. 2015. PMID: 25719313 Review.
-
Ceramide synthases at the centre of sphingolipid metabolism and biology.Biochem J. 2012 Feb 1;441(3):789-802. doi: 10.1042/BJ20111626. Biochem J. 2012. PMID: 22248339 Free PMC article. Review.
-
Ceramide synthases as potential targets for therapeutic intervention in human diseases.Biochim Biophys Acta. 2014 May;1841(5):671-81. doi: 10.1016/j.bbalip.2013.08.019. Epub 2013 Sep 8. Biochim Biophys Acta. 2014. PMID: 24021978 Review.
Cited by
-
Ceramides as Emerging Players in Cardiovascular Disease: Focus on Their Pathogenetic Effects and Regulation by Diet.Adv Nutr. 2024 Jul;15(7):100252. doi: 10.1016/j.advnut.2024.100252. Epub 2024 Jun 12. Adv Nutr. 2024. PMID: 38876397 Free PMC article. Review.
-
Hepatic-Metabolic Activity of α-Lipoic Acid-Its Influence on Sphingolipid Metabolism and PI3K/Akt/mTOR Pathway in a Rat Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.Nutrients. 2024 May 16;16(10):1501. doi: 10.3390/nu16101501. Nutrients. 2024. PMID: 38794739 Free PMC article.
-
Ionic composition of Shotokuseki extract alters cell differentiation and lipid metabolism in three-dimensional cultured human epidermis.Cytotechnology. 2024 Jun;76(3):279-290. doi: 10.1007/s10616-024-00616-3. Epub 2024 Feb 16. Cytotechnology. 2024. PMID: 38736726
-
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells.Cells. 2024 Feb 26;13(5):405. doi: 10.3390/cells13050405. Cells. 2024. PMID: 38474369 Free PMC article.
-
Metabolomic associations of impaired awareness of hypoglycaemia in type 1 diabetes.Sci Rep. 2024 Feb 23;14(1):4485. doi: 10.1038/s41598-024-55032-6. Sci Rep. 2024. PMID: 38396205 Free PMC article.
References
-
- Hannun YA. Science. 1996;274:1855–1859. - PubMed
-
- Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. Cell. 1992;71:765–776. - PubMed
-
- Brenner B, Ferlinz K, Grassme H, Weller M, Koppenhoefer U, Dichgans J, Sandhoff K, Lang F, Gulbins E. Cell Death Differ. 1998;5:29–37. - PubMed
-
- Garzotto M, White-Jones M, Jiang Y, Ehleiter D, Liao WC, Haimovitz-Friedman A, Fuks Z, Kolesnick R. Cancer Res. 1998;58:2260–2264. - PubMed
-
- Jenkins GM, Cowart LA, Signorelli P, Pettus BJ, Chalfant CE, Hannun YA. J. Biol. Chem. 2002;277:42572–42578. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources